ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan
· Delayed Price · Currency is TWD 58.70
-2.60 (-4.24%)
Mar 9, 2026, 1:45 PM CST
ACRO Biomedical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | -79.82 | -62.09 | -41.42 | -60.88 | -50.78 | -50.02 | Upgrade
|
| Depreciation & Amortization | 14.72 | 11.78 | 9.71 | 8.24 | 9.48 | 12.51 | Upgrade
|
| Other Amortization | 1.27 | 1.7 | 1.27 | 0.98 | 0.03 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.17 | 0.15 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 5.38 | 1.33 | -2.77 | -0.5 | -1.81 | - | Upgrade
|
| Stock-Based Compensation | 3.2 | 1.39 | - | 0.74 | 1.39 | 3.65 | Upgrade
|
| Provision & Write-off of Bad Debts | -1.85 | -1.85 | 3.55 | - | 0 | - | Upgrade
|
| Other Operating Activities | 3.75 | 0.35 | -20.46 | 4 | 0.53 | 0.22 | Upgrade
|
| Change in Accounts Receivable | 6 | -2.56 | 2.32 | -5.01 | -0.46 | -2.35 | Upgrade
|
| Change in Inventory | -6.11 | -1.72 | 2.9 | -1.96 | -1.69 | 1.6 | Upgrade
|
| Change in Accounts Payable | -0.36 | 0.36 | 0.09 | 0.24 | -0.13 | -0.13 | Upgrade
|
| Change in Unearned Revenue | 0.48 | 2.31 | 0.12 | -0.23 | -2.86 | 2.7 | Upgrade
|
| Change in Other Net Operating Assets | 3.29 | 5.47 | -3.58 | 9.24 | -1.52 | 0.46 | Upgrade
|
| Operating Cash Flow | -49.89 | -43.38 | -48.27 | -45.15 | -47.83 | -31.33 | Upgrade
|
| Capital Expenditures | -19.4 | -30.55 | -21 | -2.74 | -0.37 | -2.12 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.13 | -0.08 | -1.46 | -1.7 | -2.93 | -1.71 | Upgrade
|
| Investment in Securities | -340 | -272.13 | -10.6 | -4.1 | 40.21 | -71.12 | Upgrade
|
| Other Investing Activities | -1.56 | -1.92 | -0.54 | -2.01 | -0.05 | 0.26 | Upgrade
|
| Investing Cash Flow | -361.07 | -304.67 | -33.59 | -10.54 | 36.86 | -74.69 | Upgrade
|
| Long-Term Debt Repaid | - | -5.25 | -4.72 | -3.45 | -3.42 | -3.12 | Upgrade
|
| Net Debt Issued (Repaid) | -5.28 | -5.25 | -4.72 | -3.45 | -3.42 | -3.12 | Upgrade
|
| Issuance of Common Stock | - | - | 350 | 307.85 | - | 100 | Upgrade
|
| Financing Cash Flow | -5.28 | -5.25 | 345.28 | 304.4 | -3.42 | 96.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.41 | 0.89 | -1.1 | 0.88 | 1 | -0.67 | Upgrade
|
| Net Cash Flow | -418.66 | -352.41 | 262.31 | 249.58 | -13.4 | -9.8 | Upgrade
|
| Free Cash Flow | -69.3 | -73.93 | -69.27 | -47.89 | -48.2 | -33.45 | Upgrade
|
| Free Cash Flow Margin | -189.85% | -167.13% | -135.66% | -173.30% | -220.80% | -185.50% | Upgrade
|
| Free Cash Flow Per Share | -1.13 | -1.21 | -1.31 | -1.01 | -1.36 | -1.11 | Upgrade
|
| Cash Interest Paid | 0.26 | 0.29 | 0.26 | 0.1 | 0.09 | 0.1 | Upgrade
|
| Cash Income Tax Paid | 0.16 | 0.27 | 0.17 | 0.06 | - | - | Upgrade
|
| Levered Free Cash Flow | -44.55 | -54.55 | -36.11 | -27.51 | -32.07 | -20.42 | Upgrade
|
| Unlevered Free Cash Flow | -44.39 | -54.37 | -35.95 | -27.45 | -32.02 | -20.35 | Upgrade
|
| Change in Working Capital | 3.3 | 3.86 | 1.86 | 2.28 | -6.66 | 2.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.